IP Library › Granted Patent US 9,399,767
Granted Patent B2
US 9,399,767 · App. 14/191,997 · Granted Jul 26, 2016

Mutant RB69 DNA polymerase

Inventors: Marian Peris (Belmont, CA); Michael Phelan (Hayward, CA); Barnett Rosenblum (San Jose, CA); Stephen Hendricks (Los Gatos, CA)
Assignee: LIFT TECHNOLOGIES CORPORATION
C12N9/1252C12Q1/6804C12Q1/6827C12Q1/6869C12Q1/6872G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,399,767
App. No.
14/191,997
Granted
Jul 26, 2016
Kind
B2
Abstract

Provided herein are mutant DNA-dependent polymerases which are derived from, or otherwise related to, wild type RB69 DNA polymerase. These mutant polymerases are capable of selectively binding labeled nucleotides. These mutant polymerases are also capable of incorporating a variety of naturally occurring and modified nucleotides, including, for example, terminator nucleotides.

Claims (9)

1. A system comprising a mutant DNA polymerase bound to a DNA template and a primer, and a nucleotide transiently-bound to the mutant DNA polymerase, wherein the mutant DNA polymerase comprises the amino acid of SEQ ID NO:2.

2. The system of claim 1 , further comprising a metal cation that inhibits incorporation of the transiently-bound nucleotide.

3. The system of claim 2 , wherein the metal cation is selected from a group consisting of calcium, scandium, titanium, vanadium, chromium, iron, cobalt, nickel, copper, zinc, gallium, germanium, arsenic, and selenium.

4. The system of claim 1 , wherein the transiently-bound nucleotide is linked to a report moiet.

5. The system of claim 1 , wherein the mutant DNA polymerase further comprises a reporter moiety.

6. The system of claim 5 , wherein the reporter moiety comprises an energy transfer donor moiety.

7. The system of claim 5 , wherein the reporter moiety comprises a fluorescent dye or a nanoparticle.

8. The system of claim 1 , wherein the transiently-bound nucleotide comprises a reversible terminator nucleotide.

9. The system of claim 8 , wherein the reversible terminator nucleotide comprises an azidomethyl blocking group on the 3′ sugar position.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2016
From: PERIS, MARIAN; PHELAN, MICHAEL; ROSENBLUM, BARNETT B.; HENDRICKS, STEPHEN P.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 038398/0116 →
Continuity (10)
Continuation 13600416 · Aug 31, 2012
Continuation 12790768 · May 28, 2010
Continuation 14191997
Continuation 14108166 · Dec 16, 2013
Continuation 12790760 · May 28, 2010
Provisional Application 61184774 · Jun 5, 2009
Provisional Application 61242762 · Sep 15, 2009
Provisional Application 61263320 · Nov 20, 2009
Provisional Application 61295533 · Jan 15, 2010
Related Publication 20140234940A1 · Aug 21, 2014